Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis have?
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis has 533 citations in the OpenAlex counts ScholarIQ stores.
When was Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis published?
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis has 2020 year in the ScholarIQ index.
What is the open-access status of Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis?
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis has bronze oa status in the ScholarIQ index.
What is the DOI of Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis?
The DOI for Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis is on the source record.
What is the PMID of Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis?
The PMID for Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis is on the source record.
What is the OpenAlex record for Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis?
The OpenAlex for Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis is on the source record.